Tatsuo Shioda - Infectious Diseases

Author Information

Tatsuo Shioda is a distinguished researcher affiliated with the Mahidol-Osaka Center for Infectious Diseases at Mahidol University in Bangkok, Thailand, and the Research Institute for Microbial Diseases at Osaka University in Suita, Japan. His work is primarily focused on infectious diseases, and he has contributed significantly to understanding various viral infections and their implications for public health.

Research Contributions

Tatsuo Shioda has made substantial contributions to the field of infectious diseases through his research on viruses such as SARS-CoV-2, Chikungunya, and Dengue. His studies have ranged from the genetic analysis of viral strains to the examination of immune responses and vaccine development. Notable works include exploring the antibody-dependent enhancement of cytokine production by SARS-CoV-2, analyzing the spread of Chikungunya virus lineages, and investigating the genetic diversity of Dengue virus in Thailand. His research aims to improve the understanding of viral pathogenesis and inform strategies for disease prevention and treatment.

Aliases

Tatsuo Shioda is also known by other names, including T Shioda and T. Shioda. These aliases are frequently used in academic publications and citations.

Publication and Citation Metrics

Metric	Value
Total Citation Count	7408
h-index	45
Total Paper Count	251

Publications:

Antibody-Dependent Enhancement of IL-6 Production by SARS-CoV-2 Nucleocapsid Protein

DOI: 10.21203/rs.3.rs-1320609/v1

Year: 2022

Spread of a Novel Indian Ocean Lineage Carrying E1-K211E/E2-V264A of Chikungunya Virus East/Central/South African Genotype across the Indian Subcontinent, Southeast Asia, and Eastern Africa

DOI: 10.3390/microorganisms10020354

Year: 2022

Genetic Analysis of Influenza A/H1N1pdm Strains Isolated in Bangladesh in Early 2020

DOI: 10.3390/tropicalmed7030038

Year: 2022

Blastocystis spp. Subtype Distribution from Human and Animals at the Thai-Myanmar Border: The Public Health Implication

DOI: 10.1016/j.ijid.2021.12.190

Year: 2022

Preclinical study of a DNA vaccine targeting SARS-CoV-2

DOI: 10.1016/j.retram.2022.103348

Year: 2022

Identification of conserved SARS-CoV-2 spike epitopes that expand public cTfh clonotypes in mild COVID-19 patients

DOI: 10.1084/jem.20211327

Year: 2021

Prompt Reduction in CRP, IL-6, IFN-γ, IP-10, and MCP-1 and a Relatively Low Basal Ratio of Ferritin/CRP Is Possibly Associated With the Efficacy of Tocilizumab Monotherapy in Severely to Critically Ill Patients With COVID-19

DOI: 10.3389/fmed.2021.734838

Year: 2021

Genetic Diversity of Dengue Virus in Clinical Specimens from Bangkok, Thailand, during 2018–2020: Co-Circulation of All Four Serotypes with Multiple Genotypes and/or Clades

DOI: 10.3390/tropicalmed6030162

Year: 2021

Generation of macrophages with altered viral sensitivity from genome-edited rhesus macaque iPSCs to model human disease

DOI: 10.1016/j.omtm.2021.03.008

Year: 2021

Orientia tsutsugamushi and Epstein-Barr Virus in a Young Adult with Acalculous Cholecystitis: A Case Report and Epidemiology of Scrub Typhus in the Maldives

DOI: 10.20944/preprints202111.0284.v1

Year: 2021

How Does Glycolysis Relate to Infectious Diseases?

Can Antivirals Be Used for Prevention?

Why are Surveillance Systems Important?

What are the Challenges in Controlling Anopheles Mosquitoes?

How Do Polymerase Inhibitors Work?

What are Immunodeficiency Disorders?

Are There Any Side Effects of Folate Biosynthesis Inhibitors?

What are Adenoviruses?

Why Is Global Cooperation Important?

Why Use Case-Control Studies in Infectious Diseases?

Partnered Content Networks

Relevant Topics